PRehabIlitatiOn with pReoperatIve exercise and educaTion for patients undergoing major abdominal cancer surgerY: protocol for a multicentre randomised controlled TRIAL (PRIORITY TRIAL).
Cancer
Complications
Education
Exercise
Gastrointestinal
Prehabilitation
Preoperative
Randomised controlled trial
Surgery
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
22 Apr 2022
22 Apr 2022
Historique:
received:
26
12
2021
accepted:
06
04
2022
entrez:
23
4
2022
pubmed:
24
4
2022
medline:
27
4
2022
Statut:
epublish
Résumé
Radical surgery is the mainstream treatment for patients presenting with advanced primary or recurrent gastrointestinal cancers; however, the rate of postoperative complications is exceptionally high. The current evidence suggests that improving patients' fitness during the preoperative period may enhance postoperative recovery. Thus, the primary aim of this study is to establish the effectiveness of prehabilitation with a progressive, individualised, preoperative exercise and education program compared to usual care alone in reducing the proportion of patients with postoperative in-hospital complications. The secondary aims are to investigate the effectiveness of the preoperative intervention on reducing the length of intensive care unit and hospital stay, improving quality of life and morbidity, and reducing costs. This is a multi-centre, assessor-blinded, pragmatic, comparative, randomised controlled trial. A total of 172 patients undergoing pelvic exenteration, cytoreductive surgery, oesophagectomy, hepatectomy, gastrectomy or pancreatectomy will be recruited. Participants will be randomly allocated to prehabilitation with a preoperative exercise and education program (intervention group), delivered over 4 to 8 weeks before surgery by community physiotherapists/exercise physiologists, or usual care alone (control group). The intervention will comprise 12 to 24 individualised, progressive exercise sessions (including aerobic/anaerobic, resistance, and respiratory exercises), recommendations of home exercises (16 to 32 sessions), and daily incidental physical activity advice. Outcome measures will be collected at baseline, the week prior to surgery, during the hospital stay, and on the day of discharge from hospital, and 1 month and 1 months postoperatively. The primary outcome will be the development of in-hospital complications. Secondary outcomes include the length of intensive care unit and hospital stay, quality of life, postoperative morbidity and costs. The successful completion of this trial will provide robust and high-quality evidence on the efficacy of a preoperative community- and home-based exercise and education intervention on important postoperative outcomes of patients undergoing major gastrointestinal cancer surgery. This trial was registered prospectively with the Australian New Zealand Clinical Trials Registry ( ACTRN12621000617864 ) on 24th May 2021.
Sections du résumé
BACKGROUND
BACKGROUND
Radical surgery is the mainstream treatment for patients presenting with advanced primary or recurrent gastrointestinal cancers; however, the rate of postoperative complications is exceptionally high. The current evidence suggests that improving patients' fitness during the preoperative period may enhance postoperative recovery. Thus, the primary aim of this study is to establish the effectiveness of prehabilitation with a progressive, individualised, preoperative exercise and education program compared to usual care alone in reducing the proportion of patients with postoperative in-hospital complications. The secondary aims are to investigate the effectiveness of the preoperative intervention on reducing the length of intensive care unit and hospital stay, improving quality of life and morbidity, and reducing costs.
METHODS
METHODS
This is a multi-centre, assessor-blinded, pragmatic, comparative, randomised controlled trial. A total of 172 patients undergoing pelvic exenteration, cytoreductive surgery, oesophagectomy, hepatectomy, gastrectomy or pancreatectomy will be recruited. Participants will be randomly allocated to prehabilitation with a preoperative exercise and education program (intervention group), delivered over 4 to 8 weeks before surgery by community physiotherapists/exercise physiologists, or usual care alone (control group). The intervention will comprise 12 to 24 individualised, progressive exercise sessions (including aerobic/anaerobic, resistance, and respiratory exercises), recommendations of home exercises (16 to 32 sessions), and daily incidental physical activity advice. Outcome measures will be collected at baseline, the week prior to surgery, during the hospital stay, and on the day of discharge from hospital, and 1 month and 1 months postoperatively. The primary outcome will be the development of in-hospital complications. Secondary outcomes include the length of intensive care unit and hospital stay, quality of life, postoperative morbidity and costs.
DISCUSSION
CONCLUSIONS
The successful completion of this trial will provide robust and high-quality evidence on the efficacy of a preoperative community- and home-based exercise and education intervention on important postoperative outcomes of patients undergoing major gastrointestinal cancer surgery.
TRIAL REGISTRATION
BACKGROUND
This trial was registered prospectively with the Australian New Zealand Clinical Trials Registry ( ACTRN12621000617864 ) on 24th May 2021.
Identifiants
pubmed: 35459100
doi: 10.1186/s12885-022-09492-6
pii: 10.1186/s12885-022-09492-6
pmc: PMC9026022
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
443Subventions
Organisme : National Health and Medical Research Council
ID : APP1184471
Informations de copyright
© 2022. The Author(s).
Références
Br J Anaesth. 2021 Jan;126(1):181-190
pubmed: 32690247
BMJ. 2018 Jan 24;360:j5916
pubmed: 29367198
J Clin Nurs. 2005 Aug;14(7):798-804
pubmed: 16000093
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
BMJ. 2010 Mar 23;340:c869
pubmed: 20332511
Dis Colon Rectum. 2017 Jul;60(7):745-754
pubmed: 28594725
BMJ Open. 2016 Oct 6;6(10):e012153
pubmed: 27855094
Ann Surg Oncol. 2021 Nov;28(12):7120-7146
pubmed: 34101066
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Ann Am Thorac Soc. 2021 Apr;18(4):587-589
pubmed: 33792521
Ann Surg. 2018 Jan;267(1):50-56
pubmed: 28489682
BMC Cancer. 2019 Jul 4;19(1):661
pubmed: 31272406
Support Care Cancer. 2021 Feb;29(2):779-785
pubmed: 32462351
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Br J Surg. 2016 Apr;103(5):504-12
pubmed: 26864728
Br J Surg. 2013 Jan;100(1):95-104
pubmed: 23148025
BMJ Open. 2017 Aug 18;7(8):e015828
pubmed: 28821518
Br J Anaesth. 2016 May;116(5):586-9
pubmed: 27106961
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
J Gastrointest Surg. 2014 Mar;18(3):491-6
pubmed: 24234246
Lung Cancer. 2011 Dec;74(3):441-5
pubmed: 21663994
Ann Surg Oncol. 2020 Oct;27(10):3995-3996
pubmed: 32297085
BMJ. 2013 Jan 08;346:e7586
pubmed: 23303884
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Br J Surg. 2016 Oct;103(11):1548-56
pubmed: 27559684
Am J Respir Crit Care Med. 2003 Jan 15;167(2):211-77
pubmed: 12524257
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Br J Surg. 2019 Sep;106(10):1393-1403
pubmed: 31282571
Pilot Feasibility Stud. 2021 Jan 13;7(1):27
pubmed: 33441181
BMJ. 2013 Mar 25;346:f1049
pubmed: 23529982
Tech Coloproctol. 2016 Feb;20(2):81-9
pubmed: 26614304
Cancer Lett. 2014 Apr 10;345(2):153-6
pubmed: 23981579
Br J Sports Med. 2018 Mar;52(5):344
pubmed: 29437041
ANZ J Surg. 2019 Sep;89(9):1097-1101
pubmed: 31280498
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
J Health Econ. 2002 Mar;21(2):271-92
pubmed: 11939242
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Eur J Surg Oncol. 2019 Apr;45(4):510-518
pubmed: 30910052
Rev Bras Ter Intensiva. 2019;31(1):27-33
pubmed: 30892478
Qual Life Res. 2011 Nov;20(9):1447-56
pubmed: 21547359
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Trials. 2018 Feb 17;19(1):112
pubmed: 29452599
Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7
pubmed: 23851406
Eur J Surg Oncol. 2021 Apr;47(4):828-833
pubmed: 32972815
BJS Open. 2018 May 22;2(5):328-335
pubmed: 30263984
EClinicalMedicine. 2019 Apr 27;11:18-26
pubmed: 31317130
Dis Colon Rectum. 2018 Mar;61(3):400-409
pubmed: 29377872
Res Q Exerc Sport. 2000 Jun;71(2 Suppl):S114-20
pubmed: 10925833
Clin Rehabil. 2010 Jul;24(7):614-22
pubmed: 20530651
J Clin Epidemiol. 2007 Sep;60(9):919-28
pubmed: 17689808
Actas Urol Esp. 2014 Jul-Aug;38(6):378-84
pubmed: 24440083
Ann Surg Oncol. 2020 Oct;27(10):3986-3994
pubmed: 32285283